These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18178907)

  • 41. Testosterone replacement therapy and cardiovascular risk factors modification.
    Chahla EJ; Hayek ME; Morley JE
    Aging Male; 2011 Jun; 14(2):83-90. PubMed ID: 21539436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography.
    Wehr E; Pilz S; Boehm BO; März W; Grammer T; Obermayer-Pietsch B
    Eur J Heart Fail; 2011 May; 13(5):482-8. PubMed ID: 21339189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between testosterone and mortality in men: a debatable issue.
    Paparrigopoulos T; Tzavellas E; Karaiskos D; Liappas I
    Arch Intern Med; 2008 Feb; 168(3):329-30; author reply 330. PubMed ID: 18268178
    [No Abstract]   [Full Text] [Related]  

  • 44. Testosterone and diabetes. What's the connection?
    Clark W
    Diabetes Self Manag; 2004; 21(5):100-3. PubMed ID: 15586917
    [No Abstract]   [Full Text] [Related]  

  • 45. Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study.
    Firtser S; Juonala M; Magnussen CG; Jula A; Loo BM; Marniemi J; Viikari JS; Toppari J; Perheentupa A; Hutri-Kähönen N; Raitakari OT
    Atherosclerosis; 2012 May; 222(1):257-62. PubMed ID: 22420889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low serum testosterone and estradiol predict mortality in elderly men.
    Tivesten A; Vandenput L; Labrie F; Karlsson MK; Ljunggren O; Mellström D; Ohlsson C
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2482-8. PubMed ID: 19401373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low serum testosterone and mortality in male veterans.
    Shores MM; Matsumoto AM; Sloan KL; Kivlahan DR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1660-5. PubMed ID: 16908801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-nucleotide polymorphism, rs1799941 in the Sex Hormone-Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø Study.
    Svartberg J; Schirmer H; Wilsgaard T; Mathiesen EB; Njølstad I; Løchen ML; Jorde R
    Andrology; 2014 Mar; 2(2):212-8. PubMed ID: 24327369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormones and cardiovascular disease in older men.
    Yeap BB; Flicker L
    J Am Med Dir Assoc; 2014 May; 15(5):326-33. PubMed ID: 24529874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-related changes in testosterone and the role of replacement therapy in older men.
    Allan CA; McLachlan RI
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):653-70. PubMed ID: 15163327
    [No Abstract]   [Full Text] [Related]  

  • 52. Reintroducing testosterone in the db/db mouse partially restores normal glucose metabolism and insulin resistance in a leptin-independent manner.
    Yabiku K; Nakamoto K; Tokushige A
    BMC Endocr Disord; 2018 Jun; 18(1):38. PubMed ID: 29895265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leydig cell stem cells: Identification, proliferation and differentiation.
    Chen H; Wang Y; Ge R; Zirkin BR
    Mol Cell Endocrinol; 2017 Apr; 445():65-73. PubMed ID: 27743991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of seminiferous tubule-associated stem Leydig cells in adult rat testes.
    Li X; Wang Z; Jiang Z; Guo J; Zhang Y; Li C; Chung J; Folmer J; Liu J; Lian Q; Ge R; Zirkin BR; Chen H
    Proc Natl Acad Sci U S A; 2016 Mar; 113(10):2666-71. PubMed ID: 26929346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal programming of adult Leydig cell function by androgenic effects on stem/progenitor cells.
    Kilcoyne KR; Smith LB; Atanassova N; Macpherson S; McKinnell C; van den Driesche S; Jobling MS; Chambers TJ; De Gendt K; Verhoeven G; O'Hara L; Platts S; Renato de Franca L; Lara NL; Anderson RA; Sharpe RM
    Proc Natl Acad Sci U S A; 2014 May; 111(18):E1924-32. PubMed ID: 24753613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.
    Surampudi PN; Wang C; Swerdloff R
    Int J Endocrinol; 2012; 2012():625434. PubMed ID: 22505891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A practical guide to male hypogonadism in the primary care setting.
    Dandona P; Rosenberg MT
    Int J Clin Pract; 2010 May; 64(6):682-96. PubMed ID: 20518947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen deficiency: effects on body composition.
    Miller KK
    Pituitary; 2009; 12(2):116-24. PubMed ID: 18421580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Might testosterone actually reduce mortality?
    Snyder PJ
    J Clin Endocrinol Metab; 2008 Jan; 93(1):32-3. PubMed ID: 18178907
    [No Abstract]   [Full Text] [Related]  

  • 60. Relationship between serum testosterone and cardiovascular risk profile in the general population.
    Montagnana M; Lippi G
    Arch Intern Med; 2008 Jun; 168(12):1350. PubMed ID: 18574094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.